Skip to main content
. 2022 Feb 15;10:384–392. doi: 10.1016/j.xjon.2022.02.001

Figure 3.

Figure 3

The 5-year overall survival for patients by T3 disease characteristics. A, multiple T3 characteristics (23.0%) versus single T3 descriptor (28.6%). B, specific T3 characteristics (TSZ, 28.7%; CWI, 19.8%; ADN, 31.7%; multiple T3, 23.0%). Shading above and below the lines drawn indicate 95% CI. TSZ, Tumor size; CWI, chest wall invasion; ADN, additional nodule.